72 related articles for article (PubMed ID: 29549837)
1. Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Rabal O; Sánchez-Arias JA; Cuadrado-Tejedor M; de Miguel I; Pérez-González M; García-Barroso C; Ugarte A; Estella-Hermoso de Mendoza A; Sáez E; Espelosin M; Ursua S; Haizhong T; Wei W; Musheng X; Garcia-Osta A; Oyarzabal J
Eur J Med Chem; 2018 Apr; 150():506-524. PubMed ID: 29549837
[TBL] [Abstract][Full Text] [Related]
2. Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors.
ElHady AK; Shih SP; Chen YC; Liu YC; Ahmed NS; Keeton AB; Piazza GA; Engel M; Abadi AH; Abdel-Halim M
Bioorg Chem; 2020 May; 98():103742. PubMed ID: 32199305
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors.
Campiani G; Cavella C; Osko JD; Brindisi M; Relitti N; Brogi S; Saraswati AP; Federico S; Chemi G; Maramai S; Carullo G; Jaeger B; Carleo A; Benedetti R; Sarno F; Lamponi S; Rottoli P; Bargagli E; Bertucci C; Tedesco D; Herp D; Senger J; Ruberti G; Saccoccia F; Saponara S; Gorelli B; Valoti M; Kennedy B; Sundaramurthi H; Butini S; Jung M; Roach KM; Altucci L; Bradding P; Christianson DW; Gemma S; Prasse A
J Med Chem; 2021 Jul; 64(14):9960-9988. PubMed ID: 34251197
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer's Disease.
Wang L; Sun T; Wang Z; Liu H; Qiu W; Tang X; Guo H; Yang P; Chen Y; Sun H
ACS Chem Neurosci; 2023 Sep; 14(17):3226-3248. PubMed ID: 37561893
[TBL] [Abstract][Full Text] [Related]
5. Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity.
Zuccarello E; Zhang H; Acquarone E; Pham D; Staniszewski A; Deng SX; Landry DW; Arancio O; Fiorito J
Bioorg Med Chem Lett; 2023 Aug; 92():129409. PubMed ID: 37453616
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology.
Mondal P; Bai P; Gomm A; Bakiasi G; Lin CJ; Wang Y; Choi SH; Tanzi RE; Wang C; Zhang C
Adv Sci (Weinh); 2024 Jan; 11(1):e2304545. PubMed ID: 37990786
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.
Osko JD; Christianson DW
Bioorg Med Chem Lett; 2020 Apr; 30(8):127023. PubMed ID: 32067866
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.
Chen Y; Sun J; Tong H; Wang J; Cao R; Xu H; Chen L; Morisseau C; Zhang M; Shi Y; Han C; Zhuang J; Jing Y; Liu Z; Hammock BD; Chen G
J Med Chem; 2024 Feb; 67(3):2095-2117. PubMed ID: 38236416
[TBL] [Abstract][Full Text] [Related]
9. The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production.
Hsu TJ; Nepali K; Tsai CH; Imtiyaz Z; Lin FL; Hsiao G; Lai MJ; Cheng YW
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299636
[TBL] [Abstract][Full Text] [Related]
10. Identifying Phosphodiesterase-5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders.
Khan MS; Mohammad HA; Shahwan M; Yadav DK; Anwar S; Shamsi A
ChemistryOpen; 2024 May; 13(5):e202300196. PubMed ID: 38060834
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Isosteric Pyridine Analogs-Based 2-Aminothiazole: Design, Synthesis, and Potential Phosphodiesterase-5 Inhibitory Activity.
Hussein AHM; Khames AA; El-Adasy AA; Atalla AA; Abdel-Rady M; Hassan MIA; Abou-Salim MA; Elshaier YAMM; Barakat A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572094
[TBL] [Abstract][Full Text] [Related]
12. A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer.
Dong J; Zheng N; Wang X; Tang C; Yan P; Zhou HB; Huang J
Eur J Pharmacol; 2018 Jun; 828():67-79. PubMed ID: 29563065
[TBL] [Abstract][Full Text] [Related]
13. SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules.
Wang F; Zheng L; Yi Y; Yang Z; Qiu Q; Wang X; Yan W; Bai P; Yang J; Li D; Pei H; Niu T; Ye H; Nie C; Hu Y; Yang S; Wei Y; Chen L
Mol Cancer Ther; 2018 Apr; 17(4):763-775. PubMed ID: 29610282
[TBL] [Abstract][Full Text] [Related]
14. Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors.
Sellmer A; Stangl H; Beyer M; Grünstein E; Leonhardt M; Pongratz H; Eichhorn E; Elz S; Striegl B; Jenei-Lanzl Z; Dove S; Straub RH; Krämer OH; Mahboobi S
J Med Chem; 2018 Apr; 61(8):3454-3477. PubMed ID: 29589441
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
Pinazza M; Ghisi M; Minuzzo S; Agnusdei V; Fossati G; Ciminale V; Pezzè L; Ciribilli Y; Pilotto G; Venturoli C; Amadori A; Indraccolo S
Oncogene; 2018 Jul; 37(28):3839-3851. PubMed ID: 29643474
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients.
Hardy K; Smith C; Tu WJ; McCuaig R; Panikkar A; Dasari V; Wu F; Tey SK; Hill GR; Khanna R; Rao S
Blood Adv; 2018 Mar; 2(6):656-668. PubMed ID: 29563122
[TBL] [Abstract][Full Text] [Related]
17. 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
Ojha R; Huang HL; HuangFu WC; Wu YW; Nepali K; Lai MJ; Su CJ; Sung TY; Chen YL; Pan SL; Liou JP
Eur J Med Chem; 2018 Apr; 150():667-677. PubMed ID: 29567459
[TBL] [Abstract][Full Text] [Related]
18. Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity.
Lecointre B; Narozny R; Borrello MT; Senger J; Chakrabarti A; Jung M; Marek M; Romier C; Melesina J; Sippl W; Bischoff L; Ganesan A
Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685969
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors: a 2013-2017 patent survey.
Faria Freitas M; Cuendet M; Bertrand P
Expert Opin Ther Pat; 2018 Apr; ():1-17. PubMed ID: 29671355
[TBL] [Abstract][Full Text] [Related]
20. Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis.
Feng Y; Huang R; Guo F; Liang Y; Xiang J; Lei S; Shi M; Li L; Liu J; Feng Y; Ma L; Fu P
Front Pharmacol; 2018; 9():274. PubMed ID: 29632491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]